UPDATE 1-US FDA declines to approve Checkpoint The
Post# of 6
(Total Views: 112)
Posted On: 12/19/2023 9:11:23 PM
UPDATE 1-US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy
1
Mon, December 18, 2023 at 7:31 AM EST
In this article:
CKPT
-4.37%
(Adds background on therapy throughout)
Dec 18 (Reuters) - Checkpoint Therapeutics said on Monday the U.S. Food and Drug Administration declined to approve its experimental therapy to treat a type of advanced skin cancer, citing issues related to a third-party contract manufacturer.
The company filed the marketing application for the drug, Cosibelimab, its lead therapy in development, earlier this year.
1
Mon, December 18, 2023 at 7:31 AM EST
In this article:
CKPT
-4.37%
(Adds background on therapy throughout)
Dec 18 (Reuters) - Checkpoint Therapeutics said on Monday the U.S. Food and Drug Administration declined to approve its experimental therapy to treat a type of advanced skin cancer, citing issues related to a third-party contract manufacturer.
The company filed the marketing application for the drug, Cosibelimab, its lead therapy in development, earlier this year.
(0)
(0)Checkpoint Therapeutics Inc. (CKPT) Stock Research Links
Scroll down for more posts ▼